Microbiome co raises €13M | Medtronic, NVIDIA AI platform for GI | SV Bank failure & docs
Medtronic and NVIDIA Collaborate to Build AI Platform for Medical Devices (NVIDIA)
Integrating NVIDIA technology into Medtronic’s real-time AI endoscopy device to help improve patient care and outcomes. Here’s Praveen’s post on the first ever GI Genius Summit.
‘Physician payment is always in the crosshairs’: How reimbursement rates affect gastroenterologists (Becker’s GI & Endoscopy)
The combination of decreased physician reimbursements and increased procedure costs continues to put physician pay in peril.
Vivante Expands Virtual GI Care with AI-Driven Care Plans (HIT Consultant)
Users will now receive AI-driven, personalized care plans guided by an expert team of coordinated care providers including gastroenterologists, internal medicine specialists, dietitians and health coaches.
Working in healthcare hasn’t gotten better. Career changes are still rising (Linkedin)
Healthcare professionals are continuing to make job transitions at a rapid pace compared to pre-pandemic, with the number of career changes last year topping even 2021’s dramatic spike.
AI-assisted colonoscopy doesn’t always improve adenoma detection: Study (MDedge)
Computer-aided detection (CADe) during colonoscopy may not lead to major improvements in key measures, particularly in community-based settings, according to a new study.
AGA launches ‘My IBD Life’ campaign to provide resources, support for patients, physicians (Healio)
With recent data highlighting the emotional and social challenges of inflammatory bowel disease, AGA has launched the My IBD Life campaign to address the growing need for psychosocial support in patient care.
In Low-Risk Patients, Colonoscopy Interval May Go Beyond 10 Years (GI & Endoscopy News)
A negative result on a screening colonoscopy appears to be highly predictive of no colorectal cancer even when screening intervals exceed 10 years, according to a recent large study.
Silicon Valley Bank failure: What physicians need to know (Medical Economics)
Many physicians are concerned and seeking advice if they should move their money from local banks to larger banks.
Microbiome therapeutics biotech mbiomics raises €13M (Labiotech)
mbiomics said it can spearhead the emerging field of synthetic microbial consortia with the potential to revolutionize the treatment of a wide range of diseases, from cancer to inflammatory bowel diseases.
Digital Lifestyle Intervention Tools May Help Patients With NAFLD (Medscape)
Digital therapeutics (DTx), which provide evidence-based interventions through software programs, could benefit patients with nonalcoholic fatty liver disease (NAFLD), according to a new review.
Diagnosing and Treating Functional GI Disorders with a Multidisciplinary Team Approach (CDI)
Functional gastrointestinal (GI) disorders can significantly impact a patient’s quality of life, and effective diagnosis and treatment require a multidisciplinary approach.
No Clear Patterns Emerging in Crohn’s Disease Treatment Outcomes in Recent Years (HCP Live)
An overview of treatment outcomes for patients with Crohn’s disease showed no discernable patterns in clinical remission and response has emerged in recent years.
Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence (Business Wire)
The Ohio State University-led study will evaluate changes in CRC screening adherence in underserved urban and rural communities.
Research: What Happens When Private Equity Firms Buy Hospitals? (Harvard Business Review)
An analysis published in the Harvard Business Review suggests that policy discussions around private equity in healthcare should move beyond simplistic labeling of the practice as either “good” or “bad”.
Advantages Shown for Endoscopic Management of Necrotizing Pancreatitis (GI & Endoscopy News)
Endoscopic management of necrotizing pancreatitis alone or with percutaneous drainage of symptomatic pancreatic fluid collections has multiple advantages over surgery or percutaneous drainage alone.
Previse Closes $3M Seed To Tackle Early Cancer Detection And Launches Company’s First Esophageal Cancer Prognostic Test (PR Newswire)
Capsulomics, announces official rebrand as Previse and launches their first product to enable accurate prognosis and detection data for those prone to Esophageal Cancer.
Physician Suicide: Investigating Its Prevalence and Cause (Medscape)
Physicians are admired for their sacrifice and dedication. Yet beneath the surface lies a painful, quiet reality: Physicians may take their lives more than any other professional.
Partnership to Support National Gastroenterology-Focused Clinical Registry (Health IT Analytics)
The GI Quality Improvement Consortium, Inc. has tapped Health Catalyst to address data entry and management challenges within its clinical registry.